Difference between revisions of "User:Scmohr/Antibiotic-res cat page"
(New page: The established mechanisms of antibiotic resistance include the following:) |
|||
Line 1: | Line 1: | ||
+ | =Antibiotic Resistance Parts= | ||
+ | |||
+ | ==Introduction to Antibiotic Resistance== | ||
+ | |||
The established mechanisms of antibiotic resistance include the following: | The established mechanisms of antibiotic resistance include the following: | ||
+ | |||
+ | 1. Enzymes that inactivate the antibiotic [famously (a). beta-lactamases that destroy penicillins and related compounds and (b) enzymes that acetylate chloramphenicol]. | ||
+ | |||
+ | 2. Proteins that keep antibiotics from entering the cell (by blocking the outer-membrane pores), or actively pump them out after they enter. | ||
+ | |||
+ | 3. Alteration of the drug binding site (vancomycin resistance comes from a switch in the chemistry of the cell-wall cross-linking peptide). This category also includes mutations in ribosomal RNA. | ||
+ | |||
+ | 4. Substitution of an alternative metabolic pathway (as in the case of sulfonamide resistance). | ||
+ | |||
+ | ==Parts by Category== | ||
+ | |||
+ | ===1. Antibiotic-inactivating Enzymes=== | ||
+ | |||
+ | ===2. Membrane-blocking Proteins=== | ||
+ | |||
+ | ===3. Membrane-embedded Efflux Pumps=== | ||
+ | |||
+ | ===4. Altered Target Molecules=== | ||
+ | |||
+ | ===5. Components of Altered Metabolic Pathways=== |
Revision as of 15:00, 23 July 2008
Contents
Antibiotic Resistance Parts
Introduction to Antibiotic Resistance
The established mechanisms of antibiotic resistance include the following:
1. Enzymes that inactivate the antibiotic [famously (a). beta-lactamases that destroy penicillins and related compounds and (b) enzymes that acetylate chloramphenicol].
2. Proteins that keep antibiotics from entering the cell (by blocking the outer-membrane pores), or actively pump them out after they enter.
3. Alteration of the drug binding site (vancomycin resistance comes from a switch in the chemistry of the cell-wall cross-linking peptide). This category also includes mutations in ribosomal RNA.
4. Substitution of an alternative metabolic pathway (as in the case of sulfonamide resistance).